Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Nestlé S.A., Aimmune's climate commitments and reduction initiatives are influenced by its parent company's sustainability strategies.

While no direct emissions figures are provided, Aimmune is aligned with Nestlé's climate initiatives, which include targets set through the Science Based Targets initiative (SBTi) and participation in various sustainability frameworks such as CDP and RE100. These initiatives aim to significantly reduce greenhouse gas emissions across all scopes, although specific reduction targets for Aimmune have not been disclosed.

As part of its commitment to sustainability, Aimmune is expected to adhere to Nestlé's overarching climate goals, which focus on achieving net-zero emissions and promoting responsible sourcing and production practices. However, without specific emissions data or reduction targets, the precise impact of Aimmune's efforts remains unclear.